Self-management of medical abortion: a qualitative evidence synthesis

Reproductive Health Matters

Volumn 24, Issue 47, 2016, Pages 155-167

  Wainwright, Megan ^a   Colvin, Christopher J ^a   Swartz, Alison ^a   Leon, Natalie ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

medical abortion; qualitative evidence synthesis; self administration; self management; systematic review of qualitative research

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ARTICLE; COUNSELING; DRUG SELF ADMINISTRATION; FAMILY PLANNING; FIRST TRIMESTER PREGNANCY; HEALTH CARE ACCESS; HELP SEEKING BEHAVIOR; HUMAN; MEDICAL ABORTION; PERSONAL AUTONOMY; PREGNANCY TERMINATION; PRIORITY JOURNAL; PRIVACY; REMOTE SENSING; SELF CARE; SOCIAL STIGMA; TELEMEDICINE; DECISION MAKING; FEMALE; INDUCED ABORTION; PREGNANCY; QUALITATIVE RESEARCH;

ABORTION, INDUCED; CHOICE BEHAVIOR; FEMALE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; QUALITATIVE RESEARCH; SELF CARE;

EID: 84991035717     PISSN: 09688080     EISSN: 14609576     Source Type: Journal    
DOI: 10.1016/j.rhm.2016.06.008     Document Type: Article

References (53)

1. 1 Chong, E., Frye, L.J., Castle, J., et al. A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.S. Contraception 92:3 (2015), 215–219.
2. 2 Iyengar, K., Klingberg-Allvin, M., Iyengar, S.D., et al. Home use of misoprostol for early medical abortion in a low resource setting: secondary analysis of a randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica 95 (2016), 173–181.
3. 3 Raymond, E.G., Grossman, D., Wiebe, E., et al. Reaching women where they are: eliminating the initial in-person medical abortion visit. Contraception 92:3 (2015), 190–193.
4. 4 Lohr, P.A., Wade, J., Riley, L., et al. Women's opinions on the home management of early medical abortion in the UK. The Journal of Family Planning and Reproductive Health Care 36:1 (2010), 21–25.
5. 5 Cameron, S., Glasier, A., Dewart, H., et al. Women's experiences of the final stage of early medical abortion at home: results of a pilot survey. The Journal of Family Planning and Reproductive Health Care 36:4 (2010), 213–216.
6. 6 Louie, K.S., Chong, E., Tsereteli, T., et al. The introduction of first trimester medical abortion in Armenia. Reproductive Health Matters 22:44 Suppl.1 (2015), 56–66.
7. 7 Shrestha, A., Sedhai, L.B., A randomized trial of hospital vs home self-administration of vaginal misoprostol for medical abortion. Kathmandu University Medical Journal 12:47 (2014), 185–189.
8. 8 Constant, D., de Tolly, K., Harries, J., et al. Assessment of completion of early medical abortion using a text questionnaire on mobile phones compared to a self-administered paper questionnaire among women attending four clinics, Cape Town, South Africa. Reproductive Health Matters 22:44 Suppl 1 (2015), 83–93.
9. 9 Puri, M., Regmi, S., Tamang, A., et al. Road map to scaling-up: translating operations research study's results into actions for expanding medical abortion services in rural health facilities in Nepal. Health Research, Policy and Systems 12:24 (2014), 1–7.
10. 10 Whaley, N.S., Burke, A.E., Update on medical abortion: simplifying the process for women. Current Opinion in Obstetrics and Gynecology 27:6 (2015), 476–481.
11. 11 World Health Organization, Safe abortion: technical and policy guidance for health systems [Internet]. WHO. http://apps.who.int/iris/bitstream/10665/70914/1/9789241548434_eng.pdf.
12. 12 World Health Organization, Health worker roles in providing safe abortion care and post abortion contraception [Internet]. http://apps.who.int/iris/bitstream/10665/181041/1/9789241549264_eng.pdf?ua=1&ua=1, 2015.
13. 13 Colvin, C.J., de Heer, J., Winterton, L., et al. A systematic review of qualitative evidence on barriers and facilitators to the implementation of task-shifting in midwifery services. Midwifery 29:10 (2015), 1211–1221.
14. 14 Lewin, S., Glenton, C., Munthe-Kaas, H., et al. Using qualitative evidence in decision making for health and social interventions: An approach to assess confidence in findings from qualitative evidence syntheses (GRADE-CERQual). PLoS Medicine, 2015.
15. 15 Noyes, J., Lewin, S., Noyes, J., et al. Chapter 6: Supplemental Guidance on Selecting a Method of Qualitative Evidence Synthesis, and Integrating Qualitative Evidence with Cochrane Intervention Reviews. Supplementary Guidance for Inclusion of Qualitative Research in Cochrane Systematic Reviews of Interventions. Version 1 (updated August 2011): Cochrane Collaboration Qualitative Methods Group, 2011.
16. 16 Ellertson, C., Simonds, W., Winikoff, B., et al. Providing mifepristone-misoprostol medical abortion: The view from the clinic. Journal of the American Medical Women's Association, 54(2), 1999 91-6 (+ 102).
17. 17 Simonds, W., Ellertson, C., Springer, K., et al. Abortion, revised: Participants in the U.S. clinical trials evaluate mifepristone. Social Science and Medicine 46:10 (1998), 1313–1323.
18. 18 Acharya, R., Kalyanwala, S., Knowledge, attitudes, and practices of certified providers of medical abortion: Evidence from Bihar and Maharashtra, India. International Journal of Gynaecology and Obstetrics 118 (2012), S40–S46.
19. 19 Alam, A., Bracken, H., Johnston, H.B., et al. Acceptability and feasibility of mifepristone-misoprostol for menstrual regulation in Bangladesh. International Perspectives on Sexual and Reproductive Health 39:2 (2013), 79–87.
20. 20 Ganatra, B., Kalyanwala, S., Elul, B., et al. Understanding women's experiences with medical abortion: In-depth interviews with women in two Indian clinics. Global Public Health 5:4 (2010), 335–347.
21. 21 Elul, B., Pearlman, E., Sorhaindo, A., et al. In-depth interviews with medical abortion clients: Thoughts on the method and home administration of misoprostol. Journal of the American Medical Women's Association 55:3 (2000), 169–172.
22. 22 Fielding, S.L., Edmunds, E., Schaff, E.A., Having an abortion using mifepristone and home misoprostol: A qualitative analysis of women's experiences. Perspectives on Sexual and Reproductive Health 34:1 (2002), 34–40.
23. 23 Kero, A., Wulff, M., Lalos, A., Home abortion implies radical changes for women. The European Journal of Contraception & Reproductive Health Care 14:5 (2009), 324–333.
24. 24 Kero, A., Lalos, A., Wulff, M., Home abortion – experiences of male involvement. The European Journal of Contraception & Reproductive Health Care 15 (2010), 264–270.
25. 25 Grindlay, K., Lane, K., Grossman, D., Women's and providers' experiences with medical abortion provided through telemedicine: A qualitative study. Women's Health Issues 23:2 (2013), e117–e122.
26. 26 Makenzius, M., Tyden, T., Darj, E., et al. Autonomy and dependence – experiences of home abortion, contraception and prevention. Scandinavian Journal of Caring Sciences 27 (2012), 569–579.
27. 27 Petitet, P.H., Ith, L., Cockroft, M., et al. Towards safe abortion access: an exploratory study of medical abortion in Cambodia. Reproductive Health Matters, Suppl(44)(55), 2015, 47.
28. 28 Ganatra, B., Vinoj, M., Prasad, P.S., Medical abortion in Bihar and Jharkhand. 2005, IPAS, New Delhi, India.
29. 29 Mitchell, E.M.H., Kwizera, A., Usta, M., et al. Choosing early pregnancy termination methods in Urban Mozambique. Social Science & Medicine 71 (2010), 62–70.
30. 30 Nanda, P., Barva, A., Dalvie, S., et al. Exploring the transformative potential of medical abortion for women in India. 2010, International Center for Research on Women, New Delhi, India.
31. 31 Espinoza, H., Abuabara, K., Ellertson, C., Physicians' knowledge and opinions about medication abortion in four Latin American and Caribbean region countries. Contraception 70 (2004), 127–133.
32. 32 Pheterson, G., Azize, Y., Abortion practice in the Northeast Caribbean: “Just write down stomach pain”. Reproductive Health Matters 13:26 (2005), 44–53.
33. 33 Cohen, J., Ortiz, O., Llaguno, S.E., et al. Reaching women with instructions on misoprostol use in a Latin American country. Reproductive Health Matters 13:26 (2005), 84–92.
34. 34 Fiol, V., Briozzo, L., Labandera, A., et al. Improving care of women at risk of unsafe abortion: Implementing a risk-reduction model at the Uruguayan-Brazilian border. International Journal of Gynaecology and Obstetrics, 118, 2012 S21-S27.
35. 35 Nations, M.K., Misago, C., Fonseca, W., et al. Women's hidden transcripts about abortion in Brazil. Social Science and Medicine 44:12 (1997), 1833–1845.
36. 36 Sherris, J., Bingham, A., Burns, M.A., et al. Misoprostol use in developing countries: Results from a multicountry study. International Journal of Gynaecology and Obstetrics 88 (2005), 76–81.
37. 37 Arilha, M.M., Misoprostol: percursos, mediacoes e redes sociais para o acesso ao aborto medicamentoso em contextos de ilegalidade no Estado de Sao Paulo. Ciência & Saúde Coletiva 17:7 (2012), 1785–1794.
38. 38 Bury, L., Bruch, S.A., Barbery, X.M., et al. Hidden realities: What women do when they want to terminate an unwanted pregnancy in Bolivia. International Journal of Gynaecology and Obstetrics 118 (2012), S4–S9.
39. 39 Grossman, D., Holt, K., Pena, M., et al. Self-induction of abortion among women in the United States. Reproductive Health Matters 18:36 (2010), 136–146.
40. 40 Drovetta, R.I., Safe abortion information hotlines: an effective strategy for increasing women's access to safe abortions in Latin America. Reproductive Health Matters 23:45 (2015), 47–57.
41. 41 Gipson, J.D., Hirz, A.E., Avila, J.L., Perceptions and practices of illegal abortion among urban young adults in the Philippines: A qualitative study. Studies in Family Planning 42:4 (2011), 261–272.
42. 42 Subha Sri, B., Sundari Ravindran, T.K., Medical abortion: Understanding perspectives of rural and marginalized women from rural South India. International Journal of Gynaecology and Obstetrics(118), 2012, S33–S39.
43. 43 Harvey, S.M., Beckman, L.J., Branch, M.R., The relationship of contextual factors to women's perceptions of medical abortion. Health Care for Women International 23 (2002), 654–665.
44. 44 Ramos, S., Romero, M., Aizenberg, L., Women's experiences with the use of medical abortion in a legally restricted context: the case of Argentina. Reproductive Health Matters Suppl(43) (2015), 1–12.
45. 45 Barbosa, R.M., Arilha, M., A experencia brasileira com o cytotec. Estudos Feministas 2:93 (1993), 408–417.
46. 46 Barbosa, R.M., Arilha, M., The Brazilian experience with Cytotec. Studies in Family Planning 24:4 (1993), 236–240.
47. 47 Diniz, D., Madeiro, A., Cytotec e aborto: A policia, os vendedores e as mulheres. Ciência & Saúde Coletiva 17:7 (2012), 1795–1804.
48. 48 Silva do Nascimento Souza, Z.C., Freire Diniz, N.M., Menezes Couto, T., et al. Trajectoria de mulheres em situacao de aborto provocado no discurso sobre clandestinidade. Acta Paulista de Enfermagem 23:6 (2010), 732–736.
49. 49 Vallely, L.M., Homiehombo, P., Kelly-Hanku, A., et al. Unsafe abortion requiring hospital admission in the Eastern Highlands of Papua New Guinea – a descriptive study of women's and health care workers' experiences. Reproductive Health 12:22 (2015), 1–11.
50. 50 Grossman, D., Evaluation of a harm-reduction model of service delivery for women with unintended pregnancies in Peru. 2013, Ibis Reproductive Health, Oakland, CA, USA.
51. 51 Bpas, Clinical Guidelines: Early Medical Abortion. 2015, Bpas, Warwickshire, UK.
52. 52 Gold, M., Chong, E., If we can do it for misoprostol, why not for mifepristone? The case for taking mifepristone out of the office in medical abortion. Contraception 92:3 (2015), 194–196.
53. 53 Grossman, D., Goldstone, P., Mifepristone by prescription: a dream in the United States but reality in Australia. Contraception 92:3 (2015), 186–189.